Image
Paul Chew
Paul is currently President, 1Rx DigiPharm Advisory, LLC and Chief Medical Officer (CMO) for Cormedix, a company harnessing taurolidine technology to combat vascular infections. He is also on the Board of Directors and CMO for Phesi, a company applying proprietary statistical platforms and web-based analytics to optimize clinical trial design and execution in oncology, neurodegenerative disease, and rare diseases.